Select Publications
Reports
2010, Drugs that can reverse deafness: Post-exposure activation of A1 adenosine receptors mitigates noise-induced cochlear injury, British Academy of Audiology, UK, vol. 19, pp. 22-23., http://www.esrc.ac.uk/my-esrc/c96c2b90-af54-45cb-9c1f-b7ae7c92d3be
,Patents
2023, Noise-induced hearing loss susceptibility test method and test apparatus, United States, Patent No. 11850044
,2023, Electroporation system for controlled localized therapeutics delivery, New Zealand, Patent No. 737871
,2021, Electroporation system for controlled localized therapeutics delivery, Patent No. Australian 2021 pat no.2016282210; China pat no.ZL201680037448.8; India pat no. 365630, Japan pat no. 6987642
,2021, Method and apparatus for close-field electroporation, Germany, Patent No. 602014077033.9
,2019, Agent provided to the cochlea and cochlear implant, Patent No. 2453856
,2017, Method of providing agents to the cochlea, United States, Patent No. US20140194807; US20170173323; 11026842 (US 2021), http://patft.uspto.gov/netacgi/nph-Parser?Sect2=PTO1&Sect2=HITOFF&p=1&u=/netahtml/PTO/search-bool.html&r=1&f=G&l=50&d=PALL&RefSrch=yes&Query=US-9533138-B2
,Preprints
2021, Association of cochlear outer hair cell - type II spiral ganglion afferents with protection from noise-induced hearing loss, http://dx.doi.org/10.1101/2021.11.06.467554
,